Cognitive decline refers to the gradual loss of memory, attention, and executive function associated with aging or neurological disease. While mild impairment can occur naturally with age, accelerated or pathological decline often signals underlying neurodegenerative disorders such as Alzheimer’s or Parkinson’s. Understanding its biological and psychosocial factors is key to developing strategies that preserve mental health and independence.

The Cognitive Decline session focuses on identifying mechanisms driving brain aging, early biomarkers of cognitive impairment, and therapeutic pathways that slow progression. Researchers are exploring oxidative stress, neuroinflammation, and synaptic dysfunction as core contributors. Lifestyle and environmental factors such as sleep, diet, and stress also play critical roles in maintaining cognitive resilience.

At the Cognitive Health Conference, experts present studies on early-diagnosis technologies, including PET imaging, EEG markers, and AI-based cognitive assessment tools. Sessions also discuss neuroprotective interventions—ranging from pharmacologic agents to mindfulness-based cognitive training—that can delay or reverse early symptoms.

This session is ideal for neurologists, geriatricians, neuropsychologists, and public-health professionals addressing the growing burden of dementia and mild cognitive impairment worldwide. It highlights multidisciplinary prevention strategies combining neurology, nutrition, and psychology to sustain brain vitality.

Advances in Neurobiology of Aging continue to transform understanding of how genetic, vascular, and metabolic processes shape cognitive longevity.